Callio Therapeutics is developing next‐generation dual‐payload antibody drug conjugates (ADCs) for various cancers.
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account